Wai Chun Bio-Technology Ltd
00660
Company Profile
Business description
Wai Chun Bio-Technology Ltd is an investment holding company. The company has one reportable segment being Modified Starch and Other Biochemical Products. It is involved in the manufacturing and sale of modified starch and other biochemical products. Geographically, it derives a majority of its revenue from The People's Republic of China and also has its presence in Hongkong.
Contact
26 Harbour Road
Rooms 4001-02, 40th Floor, China Resources Building
Wanchai
Hong Kong
HKGT: +852 31029989
Sector
Basic Materials
Stock type
Cyclical
Industry
Chemicals
Fiscal Year End
30 June 2026
Employees
128
Stocks News & Analysis
stocks
Undervalued ASX share with plan to mitigate tariff risk
Shares have dropped 20% in the previous year due to concerns about tariffs.
stocks
Earnings up but shares overvalued for ASX gold miner
Higher gold prices are making a difference to the bottom line but investors overly optimistic.
stocks
Alphabet: Anthropic deal and Gemini momentum stand to deliver; Fair Value up 27%
We see faster cloud growth and improved longer-term profitability for Alphabet.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,295.80 | 26.20 | -0.28% |
| CAC 40 | 8,233.06 | 6.12 | -0.07% |
| DAX 40 | 24,291.82 | 16.96 | -0.07% |
| Dow JONES (US) | 47,544.59 | 337.47 | 0.71% |
| FTSE 100 | 9,667.43 | 13.61 | 0.14% |
| HKSE | 26,346.14 | 87.56 | -0.33% |
| NASDAQ | 23,637.46 | 432.59 | 1.86% |
| Nikkei 225 | 50,219.18 | 293.14 | -0.58% |
| NZX 50 Index | 13,402.66 | 11.07 | 0.08% |
| S&P 500 | 6,875.16 | 83.47 | 1.23% |
| S&P/ASX 200 | 9,012.50 | 16.30 | -0.18% |
| SSE Composite Index | 3,988.22 | 8.72 | -0.22% |